PlainRecalls
FDA Drug Low Class III Terminated

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86

Reported: February 1, 2017 Initiated: December 20, 2016 #D-0446-2017

Product Description

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86

Reason for Recall

Failed Dissolution Specifications; 18 month stability time point

Details

Units Affected
11,618 bottles
Distribution
Nationwide
Location
Cranbury, NJ

Frequently Asked Questions

What product was recalled?
buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86. Recalled by Sun Pharmaceutical Industries, Inc.. Units affected: 11,618 bottles.
Why was this product recalled?
Failed Dissolution Specifications; 18 month stability time point
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2017. Severity: Low. Recall number: D-0446-2017.